Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma.

Saved in:
Bibliographic Details
Title: Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma.
Authors: Barrios, Carlos H.1, Hernandez-Barajas, David2, Brown, Michael P.3, Lee, Se-Hoon4, Fein, Luis5, Liu, Jin-Hwang6, Hariharan, Subramanian7, Martell, Bridget A.7, Yuan, Jinyu7, Bello, Akintunde7, Wang, Zhixiao8, Mundayat, Rajiv7, Rha, Sun-Young9
Source: Cancer (0008543X). Mar2012, Vol. 118 Issue 5, p1252-1259. 8p.
Database: Academic Search Ultimate
Description
ISSN:0008543X
DOI:10.1002/cncr.26440